Case number 1:20-cv-00074
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 22, 2024 | 138 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 8,796,331; 8,877,938; 9,388,134. (Attachments: # 1 Consent Judgment and Order)(nms) (Entered: 02/22/2024) (0) |
| Feb 21, 2024 | 137 | REDACTED VERSION of 134 Proposed Consent Judgment, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 2/22/2024 (nms). (Entered: 02/21/2024) (6) |
| Feb 13, 2024 | 136 | STIPULATION and Proposed Order to Extend Time to file public version of the [Proposed] Consent Judgment and Order of Injunction to February 20, 2024 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 2/13/2024 (nms). (Entered: 02/13/2024) (3) |
| Feb 7, 2024 | 135 | [SEALED] Consent Judgment and Order of Injunction between Plaintiff and Defendants Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 2/7/2024.*This order has been emailed to local counsel. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-02021-RGA, 1:20-cv-00074-RGA, 1:22-cv-01395-RGA(nms) (Entered: 02/07/2024) (0) |
| Feb 6, 2024 | 134 | [SEALED] Proposed Consent Judgment and Order of Injunction, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 2/6/2024 (nms). (Entered: 02/06/2024) (0) |
| Jun 3, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: It appears that the 30 month stay ends no earlier than July 7, 2023. (E.g., No. 19-1979, D.I. 3). Two of the asserted patents (the 659 and the 331) are said to expire on January 14, 2023. (Id.). The other two patents (the 938 and the 134) expire in 2026 and 2027. I think Novartis told me on April 21, 2022, that the first two patents, because of pediatric (or some other) exclusivity, if valid and infringed, would actually block any launch before July 14, 2023. The parties are to advise whether I have all this right. If it is right, I expect to prioritize the invalidity and infringement proceedings relating to the second set of patents. I do not see what sense it makes to invest a lot of time and effort trying cases relating to patents that may have no practical impact and at most would have limited practical impact. If one or more generics (which, by my count, are Biocon, Laurus, Teva, MacLeods, Zydus, Hetero, and DRL (Mylans trials being in West Virginia)) are successful against the later-expiring patents, there will be other ways to resolve the 659 and 331 claims. Ordered by Judge Richard G. Andrews on 6/3/2022. Associated Cases: 1:20-md-02930-RGA et al.(nms) |
| Jun 3, 2022 | 133 | ORAL ORDER: It appears that the 30 month stay ends no earlier than July 7, 2023. (E.g., No. 19-1979, D.I. 3). Two of the asserted patents (the 659 and the 331) are said to expire on January 14, 2023. (Id.). The other two patents (the 938 and the 134) expire in 2026 and 2027. I think Novartis told me on April 21, 2022, that the first two patents, because of pediatric (or some other) exclusivity, if valid and infringed, would actually block any launch before July 14, 2023. The parties are to advise whether I have all this right. If it is right, I expect to prioritize the invalidity and infringement proceedings relating to the second set of patents. I do not see what sense it makes to invest a lot of time and effort trying cases relating to patents that may have no practical impact and at most would have limited practical impact. If one or more generics (which, by my count, are Biocon, Laurus, Teva, MacLeods, Zydus, Hetero, and DRL (Mylans trials being in West Virginia)) are successful against the later-expiring patents, there will be other ways to resolve the 659 and 331 claims. Ordered by Judge Richard G. Andrews on 6/3/2022. Associated Cases: 1:20-md-02930-RGA et al.(nms) (Entered: 06/03/2022) (0) |
| May 3, 2022 | 132 | Notice of Service (11) Docket Text: NOTICE OF SERVICE of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov on the Validity of the '659 Patent filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Apr 21, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Status/scheduling Conference held on 4/21/2022. Counsel for Plaintiff: D. Silver. Counsel for Defendants: D. Gattuso, K. Keller, J. Miller, D. Bortz, M. Haney, C. Hitch, A. Poff, J. Seaman, S. Stamoulis. The parties shall submit proposed scheduled two weeks from today. (Court Reporter Heather Triozzi.) Associated Cases: 1:20-md-02930-RGA et al.(lak) |
| Apr 20, 2022 | 130 | Notice of Service (12) Docket Text: NOTICE OF SERVICE of (1) Sur-Reply Expert Report of Francis G. Spinale, MD, PH.D. regarding Validity and (2) Sur-Reply Report of Gregory K. Bell, Ph.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Apr 20, 2022 | 131 | Notice of Service (11) Docket Text: NOTICE OF SERVICE of Sur-Reply Expert Report of Dr. Alexander M. Klibanov on the Validity of the 659 and 331 Patents filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Apr 11, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| Apr 11, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Due to a scheduling conflict the Status/Scheduling Conference scheduled for 4/20/2022, is CANCELED. The Status/Scheduling Conference is now rescheduled for 4/21/2022, at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 4/11/2022. Associated Cases: 1:20-md-02930-RGA et al.(nms) |
| Apr 4, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Status/Scheduling Conference is now set for 4/20/2022, at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 4/4/2022. Associated Cases: 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00074-RGA, 1:20-cv-00415-RGA(nms) |
| Apr 1, 2022 | 126 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Dr. Jonathan W. Steed filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Apr 1, 2022 | 127 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of the Reply Expert Report of Dan Fintel, M.D., on the Invalidity of the '659 and '331 Patents filed by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc.,, Torrent Pharmaceuticals Ltd., Hetero USA Inc..(Ormerod, Eve) |
| Mar 29, 2022 | 125 | Redacted Document (6) Docket Text: REDACTED VERSION of [123] Stipulation, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 3/29/2022 (nms). |
| Mar 21, 2022 | 122 | Status Report (17) Docket Text: JOINT Status Report, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 3/22/2022 (nms). |
| Mar 16, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties to the MDL and its member cases are to file a joint status report no later than three (3) days from the date of this Order. Specifically the parties should address (1) scheduled deadlines and events currently in place, (2) matters that are outstanding and need Court attention, and (3) for the cases related to the MDL but not member cases of the MDL, what the relationship is, including in particular what overlap (for example, the same patents, different patents but the same patent family, the same branded products, the same generic products) the related cases have with the member cases. Ordered by Judge Richard G. Andrews on 3/16/2022. Associated Cases: 1:20-md-02930-RGA et al.(nms) |
| Mar 15, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA, 1:20-cv-00074-RGA and 1:20-cv-00445-RGA (rjb) |
| Mar 15, 2022 | 120 | Order (1) Docket Text: ORDER in MDL No. 2930 Reassigning Litigation to Judge Richard G. Andrews. Signed by Karen K. Caldwell, Chair on 3/15/22. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Feb 11, 2022 | 118 | Notice of Service (17) Docket Text: NOTICE OF SERVICE of (1) Responsive Expert Report of Francis G. Spinale, MD, PHD Regarding Validity of the 659 and 331 Patents; (2) Responsive Expert Report of Dr. Alexander M. Klibanov on the Validity of the 659 and 331 Patents; and (3) Expert Report of Gregory K. Bell, PH.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Feb 11, 2022 | 119 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Responsive Expert Report of Bernhardt L. Trout, Ph.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jan 7, 2022 | 117 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Supplemental Opening Expert Report of Dr. Alexander M. Klibanov on Infringement by Defendants Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. and (2) Supplemental Opening Expert Report of Francis G. Spinale, MD, PHD, on Infringement by Defendants Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jan 6, 2022 | 116 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Appearance of Amit Singhai by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (Ormerod, Eve) |
| Dec 15, 2021 | 113 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Dan Fintel, M.D., on the Invalidity of the '659 and '331 Patents filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc..(Ormerod, Eve) |
| Dec 15, 2021 | 114 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of Opening Expert Reports filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Dec 15, 2021 | 115 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Laird Forrest Regarding Invalidity of U.S. Patent Nos. 8,101,659 and 8,796,331 filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios) |
| Dec 14, 2021 | 112 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Expert Report of Dr. Jonathan W. Steed filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc..(Weinblatt, Richard) |
| Dec 9, 2021 | 111 | Redacted Document (4) Docket Text: REDACTED VERSION of (140 in 1:19-cv-02021-LPS, 110 in 1:20-cv-00074-LPS, 447 in 1:20-md-02930-LPS) Stipulation, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Dec 7, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (140 in 1:19-cv-02021-LPS, 110 in 1:20-cv-00074-LPS, 447 in 1:20-md-02930-LPS) STIPULATION and [Proposed] Order Dismissing Novartis's '938 and '134 Patent Claims Against Alembic and Alembic's Counterclaims Against the '938 and '134 Patents filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 12/6/21. Associated Cases: 1:19-cv-02021-LPS, 1:20-cv-00074-LPS, 1:20-md-02930-LPS (ntl) |
| Nov 29, 2021 | 109 | Redacted Document (3) Docket Text: REDACTED VERSION of (420 in 1:20-md-02930-LPS, 135 in 1:19-cv-02021-LPS, 108 in 1:20-cv-00074-LPS) Stipulation by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Nov 16, 2021 | 107 | Redacted Document (17) Docket Text: REDACTED VERSION of (196 in 1:19-cv-02053-LPS, 114 in 1:20-cv-00415-LPS, 339 in 1:19-cv-01979-LPS, 132 in 1:19-cv-02021-LPS, 35 in 1:21-cv-00229-LPS, 106 in 1:20-cv-00074-LPS, 157 in 1:20-cv-00445-LPS, 407 in 1:20-md-02930-LPS) Status Report by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Nov 9, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Whitney M. Howard for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-md-02930-LPS et al.(srs) |
| Nov 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (156 in 1:20-cv-00445-LPS, 131 in 1:19-cv-02021-LPS, 105 in 1:20-cv-00074-LPS, 195 in 1:19-cv-02053-LPS, 337 in 1:19-cv-01979-LPS, 405 in 1:20-md-02930-LPS, 113 in 1:20-cv-00415-LPS) MOTION for Pro Hac Vice Appearance of Attorney Whitney Meier Howard filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 11/8/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Nov 5, 2021 | 105 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Whitney Meier Howard - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certification for Whitney Meier Howard)(Silver, Daniel) |
| Nov 5, 2021 | 105 | Certification for Whitney Meier Howard (1) |
| Nov 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (336 in 1:19-cv-01979-LPS, 104 in 1:20-cv-00074-LPS, 404 in 1:20-md-02930-LPS, 194 in 1:19-cv-02053-LPS, 130 in 1:19-cv-02021-LPS, 155 in 1:20-cv-00445-LPS, 112 in 1:20-cv-00415-LPS, 34 in 1:21-cv-00229-LPS) STIPULATION TO EXTEND TIME the Deadline for the Submissionof the Joint Status Report to November 8, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 11/4/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Nov 3, 2021 | 104 | Stipulation to EXTEND Time (12) Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Submissionof the Joint Status Report to November 8, 2021 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Oct 21, 2021 | 103 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of (1) Novartis's Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-18); (2) Novartis's Objections and Responses to Defendant Teva's First Set of Requests for Admissions (Nos. 1-9); (3) Novartis's Objections and Responses to Defendant Teva's First Set of Individual Interrogatories (Nos. 1-9); and (4) Novartis's Objections and Responses to Defendant Zydus's First Set of Requests for Admissions (Nos. 1-8) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 20, 2021 | 100 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 20, 2021 | 101 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Alembic Defendants' Response to Plaintiff's First Set of Requests for Admissions (Nos. 1-50), 2) Alembic Pharmaceuticals Limited's and Alembic Pharmaceuticals, Inc.'s Response to Novartis's Third Set of Interrogatories (No. 6), and 3) Alembic Pharmaceuticals Limited's and Alembic Pharmaceuticals, Inc.'s Response to Novartis's Fourth Set of Requests for the Production of Documents and Things (No. 75) filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Ormerod, Eve) |
| Oct 20, 2021 | 102 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Michael Motto on October 22, 2021 filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Oct 19, 2021 | 99 | Notice of Service (19) Docket Text: NOTICE OF SERVICE of Discovery Responses filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 18, 2021 | 98 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Limited's and Alembic Pharmaceuticals, Inc.'s Responses and Objections to Novartis's Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Ormerod, Eve) |
| Oct 1, 2021 | 97 | Notice to Take Deposition (8) Docket Text: NOTICE to Take Deposition of Michael Exton on October 5, 2021 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Stamoulis, Stamatios) |
| Sep 21, 2021 | 96 | Notice of Service (21) Docket Text: NOTICE OF SERVICE of (1) Novartis's Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) to Defendants, (2) Novartis's Third Set Of Interrogatories To Defendants, (3) Novartis's Fourth Set of Requests to Defendants for the Production of Documents and Things, (4) Novartis's First Set Of Requests For Admissions To Defendants, and (5) Novartis's Second Set of Common Interrogatories to Defendants filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Sep 20, 2021 | 95 | Notice of Service (19) Docket Text: NOTICE OF SERVICE of (1) Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff Pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Plaintiff's Second Supplemental Infringement Contentions Against Defendants filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Sep 17, 2021 | 94 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Joint Invalidity Contentions filed by Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc..(Dorsney, Kenneth) |
| Sep 15, 2021 | 85 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Yugang Liu on on a mutually agreed-upon date filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 86 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Sven Erik Godtfredsen on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 87 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Paul Sutton on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 88 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Bin Hu on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 89 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Lili Feng on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 90 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Mahavir Prashad on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 91 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Michael J. Girgis on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 92 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Piotr Karpinski on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 15, 2021 | 93 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Thomas J. Blacklock on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 14, 2021 | 84 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Defendant Crystal Pharma's Second Set of Individual Interrogatories (No. 4) to Plaintiff Novartis Pharmaceuticals Corporation filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 9, 2021 | 83 | Notice (Other) (2) Docket Text: NOTICE of Joinder by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (Ormerod, Eve) |
| Sep 8, 2021 | 81 | Notice to Take Deposition (19) Docket Text: NOTICE to Take Deposition of NOVARTIS PHARMACEUTICALS CORPORATION on a mutually agreed upon date and time filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 8, 2021 | 82 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Randy Lee Webb on September 24, 2021 filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Aug 31, 2021 | 80 | Notice of Service (20) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's First Supplemental Infringement Contentions Against Defendants, and (2) Novartis's First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories (Nos. 1-3) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Aug 27, 2021 | 79 | Notice of Service (15) Docket Text: NOTICE OF SERVICE of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jul 14, 2021 | 78 | Answer to Counterclaim (18) Docket Text: ANSWER to [77] Answer to Amended Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jun 23, 2021 | 77 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [75] Amended Complaint Additional Defenses and, COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals Limited.(Ormerod, Eve) |
| Jun 18, 2021 | 76 | Transcript (115) Docket Text: Official Transcript of Claim Construction Hearing held on June 8, 2021 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/9/2021. Redacted Transcript Deadline set for 7/19/2021. Release of Transcript Restriction set for 9/16/2021. (bpg) |
| Jun 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (250 in 1:20-md-02930-LPS, 85 in 1:19-cv-02021-LPS, 66 in 1:20-cv-00415-LPS, 236 in 1:19-cv-01979-LPS, 13 in 1:21-cv-00229-LPS, 115 in 1:20-cv-00445-LPS, 63 in 1:20-cv-00074-LPS, 133 in 1:19-cv-02053-LPS) STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's Amended Complaints. Signed by Judge Leonard P. Stark on 6/9/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Jun 9, 2021 | 75 | Main Document (17) Docket Text: AMENDED COMPLAINT against Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.- filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D)(Silver, Daniel) |
| Jun 9, 2021 | 75 | Exhibit A-D (67) |
| Jun 8, 2021 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing (by remote video) held on 6/8/2021. (Court Reporter B. Gaffigan.) Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Jun 8, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Jun 8, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 6/8/2021. Associated Cases: 1:19-cv-02021-LPS, 1:19-cv-02053-LPS, 1:20-cv-00074-LPS, 1:20-cv-00415-LPS, 1:20-cv-00445-LPS(dlb) |
| Jun 7, 2021 | 73 | Main Document (3) Docket Text: Letter to Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Dispute Letter - re (261 in 1:20-md-02930-LPS) Order,,. (Attachments: # (1) Exhibit A)(Silver, Daniel) |
| Jun 7, 2021 | 73 | Exhibit A (38) |
| Jun 3, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman hearing on June 8, 2021 at 10:00 a.m. is available to the public using the following dial-in for audio access: +1 646 828 7666 US -- Meeting ID: 161 238 3790 -- Passcode: 824345 -- One Tap Mobile Public Dial-In Number: +16468287666,,1612383790#,,,,*824345# US. Audio reproduction of the proceeding is strictly prohibited. ORDERED by Judge Leonard P. Stark on 6/3/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| May 25, 2021 | 71 | Main Document (2) Docket Text: Letter to Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Claim Construction Hearing. (Attachments: # (1) Exhibit 58)(Silver, Daniel) |
| May 25, 2021 | 71 | Exhibit 58 (13) |
| May 24, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' letter concerning the claim construction hearing scheduled for June 8 at 10:00 a.m. (C.A. No. 20-md-2930 D.I. 256), IT IS HEREBY ORDERED that each side will be allocated 75 minutes for its presentation. The hearing will be conducted by videoconference technology. Defendants shall submit access information for the Court, including access information for any interested member of the public, in advance of the hearing. The parties may present argument in the order they propose in the letter. IT IS FURTHER ORDERED that each party shall submit any slides or other materials to be referenced at the hearing by no later than June 7 at 4:00 p.m. ORDERED by Judge Leonard P. Stark on 5/24/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| May 21, 2021 | 66 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| May 21, 2021 | 67 | Main Document (16) Docket Text: APPENDIX re (14 in 1:21-cv-00229-LPS) Joint Claim Construction Brief, (88 in 1:19-cv-02021-LPS) Joint Claim Construction Brief, (69 in 1:20-cv-00415-LPS) Joint Claim Construction Brief, (118 in 1:20-cv-00445-LPS) Joint Claim Construction Brief, (136 in 1:19-cv-02053-LPS) Joint Claim Construction Brief, (253 in 1:20-md-02930-LPS) Joint Claim Construction Brief, (239 in 1:19-cv-01979-LPS) Joint Claim Construction Brief, (66 in 1:20-cv-00074-LPS) Joint Claim Construction Brief (Volume 1 -- Exhibits A-D) by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D)(Silver, Daniel) |
| May 21, 2021 | 67 | Exhibit A-D (431) |
| May 21, 2021 | 68 | Main Document (16) Docket Text: APPENDIX re (14 in 1:21-cv-00229-LPS) Joint Claim Construction Brief, (88 in 1:19-cv-02021-LPS) Joint Claim Construction Brief, (69 in 1:20-cv-00415-LPS) Joint Claim Construction Brief, (118 in 1:20-cv-00445-LPS) Joint Claim Construction Brief, (136 in 1:19-cv-02053-LPS) Joint Claim Construction Brief, (253 in 1:20-md-02930-LPS) Joint Claim Construction Brief, (239 in 1:19-cv-01979-LPS) Joint Claim Construction Brief, (66 in 1:20-cv-00074-LPS) Joint Claim Construction Brief (Volume 2 -- Exhibits 1-57) by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1-29, # (2) Exhibit 35-43, # (3) Exhibit 44, # (4) Exhibit 45-57)(Silver, Daniel) |
| May 21, 2021 | 68 | Exhibit 1-29 (200) |
| May 21, 2021 | 68 | Exhibit 35-43 (83) |
| May 21, 2021 | 68 | Exhibit 44 (54) |
| May 21, 2021 | 68 | Exhibit 45-57 (180) |
| May 21, 2021 | 69 | Letter (2) Docket Text: Letter to The Honorable Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Claim Construction Hearing. (Silver, Daniel) |
| May 20, 2021 | 65 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Defendants Objection to Plaintiffs Notice of Deposition of Raymond Butcher, Ph.D., Pursuant to Fed. R. Civ. P. 30(b)(1) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios) |
| May 19, 2021 | 64 | Statement (6) Docket Text: STATEMENT re (241 in 1:20-md-02930-LPS, 228 in 1:19-cv-01979-LPS) Letter Novartis's Comments on Defendants' Technology Tutorial by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| May 18, 2021 | 63 | Main Document (13) Docket Text: STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's Amended Complaints by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-N)(Silver, Daniel) |
| May 18, 2021 | 63 | Exhibit A-N (614) |
| May 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (82 in 1:19-cv-02021-LPS, 60 in 1:20-cv-00074-LPS, 112 in 1:20-cv-00445-LPS, 247 in 1:20-md-02930-LPS, 233 in 1:19-cv-01979-LPS, 63 in 1:20-cv-00415-LPS, 12 in 1:21-cv-00229-LPS, 130 in 1:19-cv-02053-LPS) STIPULATION TO EXTEND TIME for Paintiff to Amend or Supplement Pleadings to May 18, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 5/17/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| May 17, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that: (1) the claim construction hearing will be held remotely; (2) the claim construction hearing is RESCHEDULED to June 8, 2021 at 10:00 a.m.; and (3) the parties shall advise the Court, simultaneously with filing their joint claim construction brief, of the number of hours they request for the hearing and whether they prefer to proceed by video or telephone conference. ORDERED by Judge Leonard P. Stark on 5/17/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| May 17, 2021 | 62 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants' Joint Sur-Reply Claim Construction Brief [with Exhibit 57]; and, (ii) the Declaration of Raymond Butcher, Ph.D. filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| May 14, 2021 | 60 | Stipulation to EXTEND Time (13) Docket Text: STIPULATION TO EXTEND TIME Deadline for Paintiff to Amend or Supplement Pleadings to May 18, 2021 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| May 11, 2021 | 59 | Notice (Other) (5) Docket Text: NOTICE of Deposition of Raymond Butcher, Ph.D., Pursuant to Fed. R. Civ. P. 30(b)(1) by Novartis Pharmaceuticals Corporation (Silver, Daniel) |
| May 5, 2021 | 58 | Letter (1) Docket Text: Letter to The Honorable Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Plaintiff's Technology Tutorial. (Silver, Daniel) |
| Apr 29, 2021 | 57 | Notice of Service (16) Docket Text: NOTICE OF SERVICE of (1) Novartis's Reply Claim Construction Brief, (2) Declaration of Laura K. Fishwick, Esq., and (3) Reply Declaration of Alexander M. Klibanov, Ph.D. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Apr 21, 2021 | 56 | Notice of Service (15) Docket Text: NOTICE OF SERVICE of Novartis's Objections to Defendants' Notice of Deposition of Alexander M. Klibanov, Ph.D., Pursuant to Fed. R. Civ. P. 30(b)(1) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Apr 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (228 in 1:20-md-02930-LPS, 77 in 1:19-cv-02021-LPS, 55 in 1:20-cv-00074-LPS, 220 in 1:19-cv-01979-LPS) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to May 14, 2021 filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/16/21. Associated Cases: 1:19-cv-01979-LPS, 1:19-cv-02021-LPS, 1:20-cv-00074-LPS, 1:20-md-02930-LPS (ntl) |
| Apr 14, 2021 | 55 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to May 14, 2021 - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Ormerod, Eve) |
| Mar 31, 2021 | 54 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (i) Defendants' Joint Responsive Claim Construction Brief [with exhibits]; and, (ii) Declaration of Raymond Butcher, Ph.D. [with exhibits] filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Mar 30, 2021 | 53 | Notice to Take Deposition (11) Docket Text: NOTICE to Take Deposition of Alexander M. Klibanov, Ph.D., on May 5, 2021 filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Mar 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (223 in 1:20-md-02930-LPS, 52 in 1:20-cv-00074-LPS, 74 in 1:19-cv-02021-LPS, 103 in 1:20-cv-00445-LPS, 215 in 1:19-cv-01979-LPS, 122 in 1:19-cv-02053-LPS, 55 in 1:20-cv-00415-LPS) STIPULATION and [Proposed] Order Extending Deadline to Amend the Pleadings; (51 in 1:20-cv-00074-LPS, 121 in 1:19-cv-02053-LPS, 213 in 1:19-cv-01979-LPS, 54 in 1:20-cv-00415-LPS, 73 in 1:19-cv-02021-LPS, 102 in 1:20-cv-00445-LPS, 221 in 1:20-md-02930-LPS) STIPULATION and [Proposed] Order Extending Time to Meet and Confer Regarding Depositions. Signed by Judge Leonard P. Stark on 3/15/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Mar 12, 2021 | 52 | Stipulation (12) Docket Text: STIPULATION and [Proposed] Order Extending Deadline to Amend the Pleadings re (45 in 1:19-cv-02021-LPS, 33 in 1:20-cv-00415-LPS, 102 in 1:20-md-02930-LPS, 29 in 1:20-cv-00074-LPS, 78 in 1:19-cv-02053-LPS, 137 in 1:19-cv-01979-LPS, 74 in 1:20-cv-00445-LPS) Scheduling Order,, by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Mar 11, 2021 | 51 | Stipulation (12) Docket Text: STIPULATION and [Proposed] Order Extending Time to Meet and Confer Regarding Depositions by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Mar 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (213 in 1:20-md-02930-LPS, 206 in 1:19-cv-01979-LPS, 52 in 1:20-cv-00415-LPS, 99 in 1:20-cv-00445-LPS, 71 in 1:19-cv-02021-LPS, 119 in 1:19-cv-02053-LPS, 49 in 1:20-cv-00074-LPS) STIPULATION TO EXTEND TIME for the substantial completion of document production to April 14, 2021 filed by Biocon Limited, Biocon Pharma, Inc., Alkem Laboratories Ltd., Biocon Pharma Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. Signed by Judge Leonard P. Stark on 3/3/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Mar 4, 2021 | 50 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of (1) Novartiss Opening Claim Construction Brief and (2) Declaration of Alexander M. Klibanov filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Mar 1, 2021 | 49 | Stipulation to EXTEND Time (12) Docket Text: STIPULATION TO EXTEND TIME for the substantial completion of document production to April 14, 2021 - filed by Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Dorsney, Kenneth) |
| Feb 17, 2021 | 47 | Claim Construction Chart (23) Docket Text: CLAIM Construction Chart by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Feb 17, 2021 | 48 | Main Document (15) Docket Text: APPENDIX re (96 in 1:20-cv-00445-LPS, 117 in 1:19-cv-02053-LPS, 199 in 1:19-cv-01979-LPS, 69 in 1:19-cv-02021-LPS, 50 in 1:20-cv-00415-LPS, 205 in 1:20-md-02930-LPS, 47 in 1:20-cv-00074-LPS) Claim Construction Chart by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1-17, # (2) Exhibit 18-25, # (3) Exhibit 26-36)(Silver, Daniel) |
| Feb 17, 2021 | 48 | Exhibit 1-17 (163) |
| Feb 17, 2021 | 48 | Exhibit 18-25 (146) |
| Feb 17, 2021 | 48 | Exhibit 26-36 (92) |
| Feb 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (68 in 1:19-cv-02021-LPS, 196 in 1:19-cv-01979-LPS, 115 in 1:19-cv-02053-LPS, 201 in 1:20-md-02930-LPS, 49 in 1:20-cv-00415-LPS, 95 in 1:20-cv-00445-LPS, 46 in 1:20-cv-00074-LPS) STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Joint Claim Construction Chart to February 17, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 2/16/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Feb 12, 2021 | 46 | Stipulation to EXTEND Time (11) Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Joint Claim Construction Chart to February 17, 2021 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Feb 1, 2021 | 45 | Notice of Service (15) Docket Text: NOTICE OF SERVICE of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jan 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (198 in 1:20-md-02930-LPS) (44 in 1:20-cv-00074-LPS, 92 in 1:20-cv-00445-LPS, 47 in 1:20-cv-00415-LPS, 113 in 1:19-cv-02053-LPS, 66 in 1:19-cv-02021-LPS, 194 in 1:19-cv-01979-LPS) STIPULATION TO EXTEND TIME for completion of production of documents to March 15, 2021 filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc. Signed by Judge Leonard P. Stark on 1/28/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Jan 27, 2021 | 44 | Stipulation to EXTEND Time (12) Docket Text: STIPULATION TO EXTEND TIME for completion of production of documents to March 15, 2021 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Seaman, John) |
| Jan 22, 2021 | 43 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of (1) Novartis's First Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) and (2) Novartis's First Set of Common Interrogatories to Defendants filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jan 15, 2021 | 42 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Defendant Crystal Pharmaceutical (Suzhou) Co., Ltd.s First Set of Individual Interrogatories (Nos. 1-3) to Plaintiff Novartis Pharmaceuticals Corporation filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Jan 9, 2021 | 41 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Defendants Preliminary Claim Constructions and Supporting Evidence filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios) |
| Dec 7, 2020 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Joint Invalidity Contentions filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc.,, Torrent Pharmaceuticals Ltd., Dr. Reddys Laboratories, Inc., Hetero USA Inc..(Ormerod, Eve) |
| Nov 19, 2020 | 39 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic's Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 3-5) filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Ormerod, Eve) |
| Nov 16, 2020 | 38 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of Novartis's Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Nov 4, 2020 | 37 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.: Entry of appearance of attorney Eve H. Ormerod. Attorney Helena C. Rychlicki terminated. (Ormerod, Eve) |
| Oct 22, 2020 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Limited's and Alembic Pharmaceuticals, Inc.'s Response to Novartis's First Set of Interrogatories (Nos. 1-2) filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Oct 21, 2020 | 35 | Notice of Service (20) Docket Text: NOTICE OF SERVICE of (1) Novartiss Second Set of Interrogatories to Defendants (Nos. 3-5) and (2) Plaintiffs Initial Infringement Chart Against Defendants filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Oct 20, 2020 | 34 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for the Production of Documents and Things (Nos. 1-108) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Oct 15, 2020 | 33 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Defendants First Set of Interrogatories (Nos. 1-7) to Plaintiff Novartis Pharmaceuticals Corporation filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Dr. Reddys Laboratories, Inc..(Stamoulis, Stamatios) |
| Oct 2, 2020 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Limited's and Alembic Pharmaceuticals, Inc.'s Response to Novartis's Second Set of Requests for the Production of Documents and Things (Nos. 15-61) and Alembic Pharmaceuticals Limited's and Alembic Pharmaceuticals, Inc.'s Response to Novartis's Third Set of Requests for the Production of Documents and Things (Nos. 62-74) filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Oct 1, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:20-md-02930-LPS. (ntl) |
| Sep 28, 2020 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Limited's and Alembic Pharmaceuticals, Inc.'s Response to Novartis's First Set of Requests for the Production of Documents and Things (Nos. 1-14) filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Sep 22, 2020 | 30 | Notice of Service (17) Docket Text: NOTICE OF SERVICE of Novartis's First Set of Interrogatories to Defendants (Nos. 1-2) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Sep 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (24 in 1:20-cv-00074-LPS, 80 in 1:20-md-02930-LPS, 67 in 1:19-cv-02053-LPS, 40 in 1:19-cv-02021-LPS, 68 in 1:20-cv-00445-LPS, 122 in 1:19-cv-01979-LPS, 26 in 1:20-cv-00415-LPS) STIPULATED PROTECTIVE ORDER. Signed by Judge Leonard P. Stark on 9/14/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Sep 18, 2020 | 29 | Scheduling Order (24) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 10/20/2021. Status Report due by 11/3/2021. Joint Claim Construction Brief due by 5/21/2021. A Markman Hearing is set for 6/7/2021 at 12:30 PM in Courtroom 6B before Judge Leonard P. Stark. A Final Pretrial Conference is set for 8/26/2022 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 12-day Bench Trial is set for 9/8/2022 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 9/14/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Sep 17, 2020 | 28 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things (Nos. 1-108) to Plaintiff Novartis Pharmaceuticals Corporation filed by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick) |
| Sep 11, 2020 | 27 | Proposed Order (26) Docket Text: PROPOSED ORDER Scheduling by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Sep 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (42 in 1:19-cv-02021-LPS, 71 in 1:20-cv-00445-LPS, 73 in 1:19-cv-02053-LPS, 132 in 1:19-cv-01979-LPS, 26 in 1:20-cv-00074-LPS, 29 in 1:20-cv-00415-LPS, 95 in 1:20-md-02930-LPS) STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Revised Proposed Scheduling Order to September 11, 2020 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 9/8/20. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Sep 4, 2020 | 26 | Stipulation to EXTEND Time (10) Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Revised Proposed Scheduling Order to September 11, 2020 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Sep 3, 2020 | 25 | Notice of Service (19) Docket Text: NOTICE OF SERVICE of (1) Novartiss Second Set of Requests to Defendants for the Production of Documents and Things ; and (2) Novartiss Third Set of Requests to Defendants for the Production of Documents and Things filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Aug 31, 2020 | 24 | Proposed Order (30) Docket Text: PROPOSED ORDER Stipulated Protective Order by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Aug 28, 2020 | 23 | Notice of Service (19) Docket Text: NOTICE OF SERVICE of Novartis's First Set of Requests to Defendants for the Production of Documents and Things filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Aug 25, 2020 | N/A | Order (0) Docket Text: ORAL ORDER: For the reasons stated during the teleconference on August 24, 2020, IT IS HEREBY ORDERED THAT a revised version of the proposed protective order is due on August 31, 2020, and a revised version of the proposed scheduling order is due on September 4, 2020, both incorporating the dates and decisions the Court announced during the hearing, including that the bench trial (not to exceed 12 days) will be held between September 8 and 23, 2022. ORDERED by Judge Leonard P. Stark on 8/25/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Aug 24, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 8/24/2020. (Court Reporter B. Gaffigan.) Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Aug 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (61 in 1:19-cv-02053-LPS, 69 in 1:20-md-02930-LPS, 63 in 1:20-cv-00445-LPS, 19 in 1:20-cv-00074-LPS, 112 in 1:19-cv-01979-LPS, 21 in 1:20-cv-00415-LPS, 33 in 1:19-cv-02021-LPS) STIPULATION TO EXTEND TIME for parties to submit a proposed scheduling order, proposed protective order, and letters regarding the disputed provisions to August 18, 2020 at 12:00 p.m. EST filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 8/20/20. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Aug 18, 2020 | 20 | Main Document (10) Docket Text: Joint Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Regarding Disputed Provisions of Proposed Scheduling Order. (Attachments: # (1) Exhibit A-K, # (2) Text of Proposed Order [Reflecting Parties' Disagreements])(Silver, Daniel) |
| Aug 18, 2020 | 20 | Exhibit A-K (224) |
| Aug 18, 2020 | 20 | Text of Proposed Order [Reflecting Parties' Disagreements] (37) |
| Aug 18, 2020 | 21 | Main Document (9) Docket Text: Joint Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Disputed Provisions of Proposed Protective Order. (Attachments: # (1) Exhibit 1-2, # (2) Text of Proposed Order [Reflecting Parties' Disagreements])(Silver, Daniel) |
| Aug 18, 2020 | 21 | Exhibit 1-2 (16) |
| Aug 18, 2020 | 21 | Text of Proposed Order [Reflecting Parties' Disagreements] (49) |
| Aug 17, 2020 | 19 | Stipulation to EXTEND Time (11) Docket Text: STIPULATION TO EXTEND TIME for parties to submit a proposed scheduling order, proposed protective order, and letters regarding the disputed provisions to August 18, 2020 at 12:00 p.m. EST - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Jul 27, 2020 | 18 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Rule 26(A)(1) Initial Disclosures; (2) Plaintiffs Initial Paragraph 3 Disclosures Regarding Electronic Systems Information; and (3) Plaintiffs Identification of Asserted patents and Accused Products pursuant to Paragraph 4(a) of the Delaware Default Standard for Discovery filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jul 10, 2020 | 17 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures and Core Technical Documents filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Rychlicki, Helena) |
| Apr 7, 2020 | 16 | Answer to Counterclaim (18) Docket Text: ANSWER to [13] Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Apr 6, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Stuart D. Sender for Alembic Pharmaceuticals Limited,Stuart D. Sender for Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Apr 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/2/20. (ntl) |
| Mar 31, 2020 | 15 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Attachments: # (1) Certificate of Service)(Rychlicki, Helena) |
| Mar 31, 2020 | 15 | Certificate of Service (1) |
| Mar 17, 2020 | 13 | Main Document (26) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals Limited. (Attachments: # (1) Certificate of Service to Answer)(Rychlicki, Helena) |
| Mar 17, 2020 | 13 | Certificate of Service to Answer (1) |
| Mar 17, 2020 | 14 | Main Document (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Attachments: # (1) Certificate of Service to Rule 7.1 Disclosure Statement)(Rychlicki, Helena) |
| Mar 17, 2020 | 14 | Certificate of Service to Rule 7.1 Disclosure Statement (1) |
| Mar 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Frank D. Rodriguez for Alembic Pharmaceuticals Limited,Frank D. Rodriguez for Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Mar 2, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amit Singhai for Alembic Pharmaceuticals Limited, and Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02021-LPS, 1:20-cv-00074-LPS(sam) |
| Feb 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jared L. Stringham, and Nicholas N. Kallas for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01979-LPS, 1:19-cv-02021-LPS, 1:19-cv-02053-LPS, 1:20-cv-00074-LPS(sam) |
| Feb 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc., [12] MOTION for Pro Hac Vice Appearance of Attorney Amit Singhai filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 2/28/20. (ntl) |
| Feb 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (63 in 1:19-cv-01979-LPS, 43 in 1:19-cv-02053-LPS, 23 in 1:19-cv-02021-LPS, 10 in 1:20-cv-00074-LPS) MOTION for Pro Hac Vice Appearance of Attorney Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 2/27/20. Associated Cases: 1:19-cv-01979-LPS, 1:19-cv-02021-LPS, 1:19-cv-02053-LPS, 1:20-cv-00074-LPS (ntl) |
| Feb 27, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christina Schwarz for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01979-LPS, 1:19-cv-02021-LPS, 1:19-cv-02053-LPS, 1:20-cv-00074-LPS(kmd) |
| Feb 27, 2020 | 11 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Attachments: # (1) Certificate of Service)(Rychlicki, Helena) |
| Feb 27, 2020 | 11 | Certificate of Service (1) |
| Feb 27, 2020 | 12 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amit Singhai - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Attachments: # (1) Certificate of Service)(Rychlicki, Helena) |
| Feb 27, 2020 | 12 | Certificate of Service (1) |
| Feb 25, 2020 | 10 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certifications for Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham)(Silver, Daniel) |
| Feb 25, 2020 | 10 | Certifications for Nichols N. Kallas, Christina Schwarz, and Jared L. Stringham (3) |
| Feb 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION and Order Dismissing Alembic Global Holdings SA Without Prejudice and Amending Caption to Reflect Same filed by Novartis Pharmaceuticals Corporation -- Party Alembic Global Holding SA terminated. Signed by Judge Leonard P. Stark on 2/11/20. (ntl) |
| Feb 7, 2020 | 8 | Main Document (1) Docket Text: NOTICE of Appearance by Helena C. Rychlicki on behalf of All Defendants (Attachments: # (1) Certificate of Service)(Rychlicki, Helena) |
| Feb 7, 2020 | 8 | Certificate of Service (1) |
| Feb 7, 2020 | 9 | Stipulation (5) Docket Text: STIPULATION and Order Dismissing Alembic Global Holdings SA Without Prejudice and Amending Caption to Reflect Same by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Jan 23, 2020 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Alembic Pharmaceuticals, Inc. waiver sent on 1/17/2020, answer due 3/17/2020. (Silver, Daniel) |
| Jan 23, 2020 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Alembic Pharmaceuticals Limited waiver sent on 1/17/2020, answer due 3/17/2020. (Silver, Daniel) |
| Jan 22, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Jan 17, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (kmd) |
| Jan 17, 2020 | 1 | Main Document (17) Docket Text: COMPLAINT filed against Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2828380.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibits A-D, # (2) Civil Cover Sheet)(kmd) |
| Jan 17, 2020 | 1 | Exhibit A-D (63) |
| Jan 17, 2020 | 1 | Civil Cover Sheet (2) |
| Jan 17, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Jan 17, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/4/2019. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 7/7/2023. (kmd) |
| Jan 17, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 8,796,331; 8,877,938; 9,388,134. (kmd) |
| Jan 17, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (kmd) |
| Jan 17, 2020 | 1 | Complaint* (1) |
